GSK continues to build the case for its multiple myeloma therapy Blenrep, which was pulled from the US market last year, with another positive phase 3 trial. The BCMA-targeted antibody-drug conjugate ...

Space is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.